Literature DB >> 31486053

A p.Arg499His Mutation in SPAST Is Associated with Infantile Onset Ascending Spastic Paralysis Complicated with Dysarthria and Anarthria.

Masashi Ogasawara1, Takashi Saito1, Eriko Koshimizu2, Noriyuki Akasaka3, Masayuki Sasaki1.   

Abstract

The complication of anarthria in hereditary spastic paraplegia (HSP) patients has been reported to result from mutations in either ALS2 or FA2H. Here, we present a case of a 12-year-old boy with hereditary spastic paralysis and anarthria associated with a SPAST mutation. Initial presentation was at 14 months of age, when the patient experienced leg stiffness. At 3 years of age, he could speak well using sentences. At 9 years of age, he was found to have dysarthria and had difficulty writing. At 12 years of age, the ability to speak was lost. The patient could not vocalize any words, despite contraction of his neck and respiratory muscles during attempted vocalization. Additionally, the patient has never walked independently in his life. Considering these symptoms, we diagnosed him as having infantile onset ascending hereditary spastic paralysis (IAHSP) complicated with anarthria. By whole-exome sequencing, we discovered a heterozygous SPAST mutation c.1496G > A (p.Arg499His), which was not found in the parents and is probably de novo. This mutation was already repeatedly described with similar phenotype. Our results suggest that the p.Arg499His mutation in SPAST should be considered as a differential diagnosis in IAHSP. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31486053     DOI: 10.1055/s-0039-1694973

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development.

Authors:  Antony Kaspi; Angela T Morgan; Michael S Hildebrand; Victoria E Jackson; Ruth Braden; Olivia van Reyk; Tegan Howell; Simone Debono; Mariana Lauretta; Lottie Morison; Matthew J Coleman; Richard Webster; David Coman; Himanshu Goel; Mathew Wallis; Gabriel Dabscheck; Lilian Downie; Emma K Baker; Bronwyn Parry-Fielder; Kirrie Ballard; Eva Harrold; Shaun Ziegenfusz; Mark F Bennett; Erandee Robertson; Longfei Wang; Amber Boys; Simon E Fisher; David J Amor; Ingrid E Scheffer; Melanie Bahlo
Journal:  Mol Psychiatry       Date:  2022-09-18       Impact factor: 13.437

2.  Evidence of mosaicism in SPAST variant carriers in four French families.

Authors:  Chloé Angelini; Cyril Goizet; Samia Ait Said; William Camu; Christel Depienne; Bénédicte Heron; Bophara Kol; Marine Guillaud-Bataille; Perrine Pennamen; Caroline Rooryck; Clarisse Scherer-Gagou; Laurène Tissier; Giovanni Stevanin; Eric Leguern; Guillaume Banneau
Journal:  Eur J Hum Genet       Date:  2021-05-06       Impact factor: 5.351

3.  De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy.

Authors:  Aristides Hadjinicolaou; Kathie J Ngo; Daniel Y Conway; John P Provias; Steven K Baker; Lauren I Brady; Craig L Bennett; Albert R La Spada; Brent L Fogel; Grace Yoon
Journal:  Acta Neuropathol Commun       Date:  2021-12-18       Impact factor: 7.801

4.  A Chinese Patient with Spastic Paraplegia Type 4 with a De Novo Mutation in the SPAST Gene.

Authors:  Li Xu; Zijuan Peng; Chunhui Zhou; Jiqing Wang; Hunjin Luo; Qin Lu; Zhengjun Bao
Journal:  Case Rep Genet       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.